Variant Bio
Seattle
About Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics. The company's focus is to identify individuals and populations around the world who are extreme outliers for traits of medical relevance and to use innovative sequencing and analytic approaches to identify genes and pathways linked to these traits. Variant Bio was founded in 2018 and headquartered in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $129.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2021)
- Website: variantbio.com
Industries & Categories
Biotechnology, Genetics, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/variant-bio-11590 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.